Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Optimal Timing and Impact of Allogeneic Peripheral Blood Stem Cell Transplantation in Adult T-Cell Lymphoblastic Lymphoma: Insights from a Large Cohort Multi-Center Real-World Study in Shanghai

Fangfang Yu, Jiahua Niu, Jianmin Yang, Jian Hou, Siguo Hao, Aibin Liang, Hong Xiong, Qi Zhu, Ligen Liu, Jun Shi, Juan Du, Bobin Chen, Rong Wei, Wenli Zhao, Lihua Sun, Yunhua Hou, Rong Tao, Xianmin Song

Blood (2024) 144 (Supplement 1): 7818.

https://doi.org/10.1182/blood-2024-199964

Published: 2024

Journal Articles

Safety and Efficacy of R-PAD Regimen in Patients with Severe Multiple Center Idiopathic Castleman Disease: A Retrospective Case Series

Yingting Lu, Chunrong Ying, Ligen Liu, Limin Zhao, Xuewei Jiang, Tinghua Zhang, Zhizhi Zhang, Xiang Zhou, Li Chang, Xinying Zhu, Chao Du, Li Yang

Blood (2024) 144 (Supplement 1): 6888.

https://doi.org/10.1182/blood-2024-207982

Published: 2024

Journal Articles

Safety and Efficacy of Ivosidenib Based Regimen in Patients with IDH1 Mutanted Acute Myeloid Leukemia: A Retrospective Case Series

Limin Zhao, Ligen Liu, Li Yang, Fangli Chen, Xuewei Jiang, Tinghua Zhang, Zhizhi Zhang, Xiang Zhou, Li Chang, Xinying Zhu, Chao Du, Chunrong Ying

Blood (2024) 144 (Supplement 1): 6055.

https://doi.org/10.1182/blood-2024-207516

Published: 2024

Journal Articles

Mastl Is a New Therapeutic Target for Acute Myeloid Leukemia

Fangli Chen, Ligen Liu, Huijie Chen, Yicheng Wu, Yuanqin Wang, Zhen Fu, Tinghua Zhang, Xuewei Jiang, Yingting Lu, Limin Zhao, Jutang Li, Li Yang

Blood (2024) 144 (Supplement 1): 5842.

https://doi.org/10.1182/blood-2024-207505

Published: 2024

Journal Articles

High Remission Rates in Relapsed/Refractory Acute Myeloid Leukemia with QHRD107 (CDK9 Inhibitor), Venetoclax, and Azacitidine Combination Therapy (107VA regimen) : Preliminary Results of a Phase 2a Study

Blood (2024) 144 (Supplement 1): 2882.

https://doi.org/10.1182/blood-2024-199412

Published: 2024

Journal Articles

Selinexor in Combination with Venetoclax and Azacitidine for Newly Diagnosed (ND) Unfit Acute Myeloid Leukemia (AML): A Multicenter, Open-Label Prospective Study

Li Yang, Fangli Chen, Hong Liang, Yunsong Bai, Wenzhong Wu, Xiaojing Yan, Jinhai Ren, Si Li, Yang Yu, Laigen Tong, Deng Pan, Ligen Liu

Blood (2023) 142 (Supplement 1): 55.

https://doi.org/10.1182/blood-2023-184581

Published: 2023

Journal Articles

Optimization of Idarubicin and Cytarabine Induction Regimen with Homoharringtonine for Newly Diagnosed AML Based on the Peripheral Blast Clearance Rate: First Result of the Multicenter, Randomized, Phase 3 Trial (RJ-AML 2016)

Yunxiang Zhang, Qiusheng Chen, Xiangqin Weng, Yang Shen, Wen Wu, Jiong Hu, Jie Hao, Ligen Liu, Junmin Li

Blood (2023) 142 (Supplement 1): 829.

https://doi.org/10.1182/blood-2023-179311

Published: 2023

Journal Articles

A Phase Ib Study of Linperlisib Monotherapy in Patients with Relapsed or Refractory B-Cell Malignancies

Wei Liu, Yunhong Huang, Haiyan Yang, Zhiming Li, Zhen Cai, Zhen Wang, Lihong Liu, Ye Guo, Ligen Liu, Rui Huang, Xu Ye, Lugui Qiu

Blood (2023) 142 (Supplement 1): 1722.

https://doi.org/10.1182/blood-2023-177550

Published: 2023

Journal Articles

Real-World Outcomes of Zanubrutinib Monotherapy in Chronic Lymphocytic Leukemia: A Multicenter Retrospective Study

Jing Luo, Jiaojiao Zhang, Ligen Liu, Rong Wei, Yonghua Yao, Min Xu, Jie Xu, Jumei Shi, Jianmin Yang, Jian Hou, Jin Wang, Jian-Qing Mi

Blood (2023) 142 (Supplement 1): 6540.

https://doi.org/10.1182/blood-2023-180477

Published: 2023

Journal Articles

Preliminary Results of a Phase 2 Study of IMM01 Combined with Azacitidine (AZA) As the First-Line Treatment in Adult Patients with Higher Risk Myelodysplastic Syndromes (MDS)

Blood (2023) 142 (Supplement 1): 320.

https://doi.org/10.1182/blood-2023-174420

Published: 2023

Journal Articles

Endothelial cell-derived angiopoietin-like protein 2 supports hematopoietic stem cell activities in bone marrow niches

Zhuo Yu, Wenqian Yang, Xiaoxiao He, Chiqi Chen, Wenrui Li, Limin Zhao, Ligen Liu, Junling Liu, Li Xie, Yaping Zhang, Junke Zheng

Blood (2022) 139 (10): 1529–1540.

https://doi.org/10.1182/blood.2021011644

Published: 2022

Includes: Supplemental data

Journal Articles

Gilteritinib Versus Salvage Chemotherapy for Relapsed/Refractory FLT3 -Mutated Acute Myeloid Leukemia: A Phase 3, Randomized, Multicenter, Open-Label Trial in Asia

Blood (2021) 138 (Supplement 1): 695.

https://doi.org/10.1182/blood-2021-145436

Published: 2021

Journal Articles

A Phase1b Clinical Study of the Oral PI3Kδ Inhibitor, Linperlisib, in Patients with B-Cell Lymphomas

Lugui Qiu, Zhiming Li, Yunhong Huang, Ligen Liu, Lihong Liu, Ye Guo, Lan Deng, Haiyan Yang, Zhen CAI, Xu Ye, Zhen Wang, Hanying Bao, Zusheng Xu, Binghua Zheng

Blood (2021) 138 (Supplement 1): 3576.

https://doi.org/10.1182/blood-2021-148276

Published: 2021

Journal Articles

Clinical Efficacy Analysis of the Low-Dose Decitabine in Combination with Cytarabine, All-Trans Retinoic Acid and Granulocyte Colony-Stimulating Factor for Patients with MDS-EB

Ligen Liu, Yuanmmei Zhai, Li Yang, Limin Zhao, Li Chang, Chunrong Yin, Yingting Lu, Xuewei Jiang, Zhizhi Zhang

Blood (2021) 138 (Supplement 1): 3685.

https://doi.org/10.1182/blood-2021-144631

Published: 2021

Journal Articles

ANGPTL2-Containing Exosomes from Vascular Endothelial Cells Promote Leukemia Development

Guohuan Sun, Dan Huang, Xiaoxin Hao, Xiaoxiao He, Zhaofeng Zheng, Chiqi Chen, Zhuo Yu, Li Xie, Shihui Ma, MD, Ligen Liu, Bo Zhou, Hui Cheng, Junke Zheng, Tao Cheng

Blood (2020) 136 (Supplement 1): 18.

https://doi.org/10.1182/blood-2020-140254

Published: 2020

Journal Articles

MDH1-mediated malate-aspartate NADH shuttle maintains the activity levels of fetal liver hematopoietic stem cells

Blood (2020) 136 (5): 553–571.

https://doi.org/10.1182/blood.2019003940

Published: 2020

Includes: Multimedia, Supplemental data

Journal Articles

The Efficacy and Safety of Decitabine in Combination with ATRA, G-CSF and Low Dose Cytarabine(Dlaag Regimen)in Relapsed/Refractory Acute Myeloid Leukemia Not Suitable for Strong Chemotherapy : A Phase 2, Prospective, Single-Arm, Multicenter Study

Li Yang, Ligen Liu, Limin Zhao, Yingting Lu, Jing Zhang, Lihua Sun

Blood (2019) 134 (Supplement_1): 5108.

https://doi.org/10.1182/blood-2019-131671

Published: 2019

Journal Articles

The Efficacy and Safety of Cladribine in Combination with Cytarabine ,ATRA, G-CSF and Mitoxantrone(Claag-M Regimen)in Relapsed/Refractory AML : A Phase 1/2, Prospective, Single-Arm, Multicenter Study

Tinghua Zhang, Yinghua Xie, Limin Zhao, Xiyao Han, Yingting Lu, Jing Zhang, Yanhui Xie, Qi Zhu, Lihua Sun, Li Yang, Ligen Liu

Blood (2019) 134 (Supplement_1): 3843.

https://doi.org/10.1182/blood-2019-125739

Published: 2019

Journal Articles

CD19-Directed Fast CART Therapy for Relapsed/Refractory Acute Lymphoblastic Leukemia: From Bench to Bedside

Cheng Zhang, Jiaping He, Li Liu, Jishi Wang, PhD, Sanbin Wang, Ligen Liu, Lei Gao, Li Gao, Yao Liu, Peiyan Kong, Jia Liu, Yu Han, Yongliang Zhang, Zhe Sun, Xun Ye, Yan He, Lianjun Shen, MD PhD, Wei Cao, Xi Zhang

Blood (2019) 134 (Supplement_1): 1340.

https://doi.org/10.1182/blood-2019-128006

Published: 2019

NARROW

Optimal Timing and Impact of Allogeneic Peripheral Blood Stem Cell Transplantation in Adult T-Cell Lymphoblastic Lymphoma: Insights from a Large Cohort Multi-Center Real-World Study in Shanghai

Safety and Efficacy of R-PAD Regimen in Patients with Severe Multiple Center Idiopathic Castleman Disease: A Retrospective Case Series

Safety and Efficacy of Ivosidenib Based Regimen in Patients with IDH1 Mutanted Acute Myeloid Leukemia: A Retrospective Case Series

Mastl Is a New Therapeutic Target for Acute Myeloid Leukemia

High Remission Rates in Relapsed/Refractory Acute Myeloid Leukemia with QHRD107 (CDK9 Inhibitor), Venetoclax, and Azacitidine Combination Therapy (107VA regimen) : Preliminary Results of a Phase 2a Study

Selinexor in Combination with Venetoclax and Azacitidine for Newly Diagnosed (ND) Unfit Acute Myeloid Leukemia (AML): A Multicenter, Open-Label Prospective Study

Optimization of Idarubicin and Cytarabine Induction Regimen with Homoharringtonine for Newly Diagnosed AML Based on the Peripheral Blast Clearance Rate: First Result of the Multicenter, Randomized, Phase 3 Trial (RJ-AML 2016)

A Phase Ib Study of Linperlisib Monotherapy in Patients with Relapsed or Refractory B-Cell Malignancies

Real-World Outcomes of Zanubrutinib Monotherapy in Chronic Lymphocytic Leukemia: A Multicenter Retrospective Study

Preliminary Results of a Phase 2 Study of IMM01 Combined with Azacitidine (AZA) As the First-Line Treatment in Adult Patients with Higher Risk Myelodysplastic Syndromes (MDS)

Endothelial cell-derived angiopoietin-like protein 2 supports hematopoietic stem cell activities in bone marrow niches

Gilteritinib Versus Salvage Chemotherapy for Relapsed/Refractory FLT3 -Mutated Acute Myeloid Leukemia: A Phase 3, Randomized, Multicenter, Open-Label Trial in Asia

A Phase1b Clinical Study of the Oral PI3Kδ Inhibitor, Linperlisib, in Patients with B-Cell Lymphomas

Clinical Efficacy Analysis of the Low-Dose Decitabine in Combination with Cytarabine, All-Trans Retinoic Acid and Granulocyte Colony-Stimulating Factor for Patients with MDS-EB

ANGPTL2-Containing Exosomes from Vascular Endothelial Cells Promote Leukemia Development

MDH1-mediated malate-aspartate NADH shuttle maintains the activity levels of fetal liver hematopoietic stem cells

The Efficacy and Safety of Decitabine in Combination with ATRA, G-CSF and Low Dose Cytarabine(Dlaag Regimen)in Relapsed/Refractory Acute Myeloid Leukemia Not Suitable for Strong Chemotherapy : A Phase 2, Prospective, Single-Arm, Multicenter Study

The Efficacy and Safety of Cladribine in Combination with Cytarabine ,ATRA, G-CSF and Mitoxantrone(Claag-M Regimen)in Relapsed/Refractory AML : A Phase 1/2, Prospective, Single-Arm, Multicenter Study

CD19-Directed Fast CART Therapy for Relapsed/Refractory Acute Lymphoblastic Leukemia: From Bench to Bedside

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only